Thank you for visiting the North Yorkshire Local Dental Committee

National Dental News

• PRF in dentistry: translating platelet-rich fibrin biology into everyday practice
  Ahead of her Dentistry Show London 2026 presentation, Emily Lu discusses the growing role of platelet-rich fibrin (PRF) in everyday clinical practice. Platelet-rich fibrin (PRF) has attracted considerable interest in recent years. What has driven that momentum, and why is it becoming increasingly relevant in everyday clinical practice? I think it has been driven by…
• Supply-cost drift: the hidden cost multiplier cutting your practice value
  Tim Doswell reflects on the stark financial reality of supply-cost drift, explaining how unexamined overhead compounds into a devastating penalty when a buyer calculates your EBITDA. Practice valuation is a function of earnings before interest, taxes, depreciation, and amortisation (EBITDA), and EBITDA is a function of overhead. Most of us focus on the wrong end…
• Dental technician workforce continues decline while overall DCP numbers rise by 5%
  The number of dental technicians on the UK register has fallen for the sixth consecutive year, despite the overall dental care professional register growing by almost 5%. Annual renewal statistics from the General Dental Council (GDC) showed that 84,746 dental care professionals (DCPs) were registered in 2026, an increase of 3,746 compared with the equivalent…
• Tooth regrowth in adults: what we know so far
  Many studies have explored the possibility of regenerating natural teeth in recent years. We review the research to determine how and when tooth regrowth might be possible in the future. According to the World Health Organization (WHO), the global prevalence of complete tooth loss stands at 7% among those aged 20 and over. For those…
• Tooth regrowth drug trial planned for 24 children in Japan
  A planned Phase IIa trial of an experimental tooth regeneration drug will involve 24 children with severe congenital tooth agenesis, Toregem BioPharma has said. The Japanese biotechnology company said the Pharmaceuticals and Medical Devices Agency (PMDA) had completed its investigation of the clinical trial notification for a tooth regrowth medicine called TRG035. Toregem said the…